Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transcutaneous Electrical Acupoint Stimulation for Cisplatin-Induced Nausea and Vomiting
NCT07509905Completed
- Sponsor
- Cairo University
- Start
- Oct 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
Trial in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Cairo University. Primary endpoint: Assessment of nausea. Started Oct 2025; status: completed.
02
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07509905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07509905.